Long-term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis

Complex Correlates of Protection After Vaccination

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients

(2012) Jérôme Pacanowski et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen

(2012) Chloe Kaech et al.   JOURNAL OF INFECTION

The Recombinant Hepatitis B Surface Antigen Vaccine in Persons With HIV: Is Seroconversion Sufficient for Long-term Protection?

(2012) Jeff E. Powis et al.   JOURNAL OF INFECTIOUS DISEASES

Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients

(2012) Ching-Lan Lu et al.   VACCINE

Long-Term Persistence of Humoral Immunity After Hepatitis A Vaccination in HIV-Infected Adults

(2011) Solen Kernéis et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1

(2011) Odile Launay   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term Durability of Immune Responses After Hepatitis A Vaccination Among HIV-Infected Adults

(2011) Nancy F. Crum-Cianflone et al.   JOURNAL OF INFECTIOUS DISEASES

Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi

(2011) Ashley Fowlkes et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy

(2011) Mongkol Lao-araya et al.   VACCINE

Do children infected with HIV receiving HAART need to be revaccinated?

(2010) Catherine G Sutcliffe et al.   LANCET INFECTIOUS DISEASES

A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine

(2010) Thanyawee Puthanakit et al.   VACCINE

Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients

(2009) Olivia Veit et al.   CLINICAL INFECTIOUS DISEASES

Immunization for HIV-positive individuals

(2009) Anna Maria Geretti et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy*

(2009) C-C Hung et al.   HIV MEDICINE

Immunogenicity and Immunologic Memory after Hepatitis B Virus Booster Vaccination in HIV‐Infected Children Receiving Highly Active Antiretroviral Therapy

(2009) Mark J. Abzug et al.   JOURNAL OF INFECTIOUS DISEASES

Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV‐Infected and HIV‐Uninfected Children 5 Years after Vaccination

(2009) Shabir A. Madhi et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccination in the Immunocompromised Child

(2009) Mark J. Abzug   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immune Responses to Measles and Tetanus Vaccines Among Kenyan Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Children Pre- and Post-Highly Active Antiretroviral Therapy and Revaccination

(2009) Carey Farquhar et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children

(2009) S. Pensieroso et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART

(2009) Pablo F. Belaunzarán-Zamudio et al.   VACCINE

Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART

(2009) Silvana D. Pessoa et al.   VACCINE

CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 Years

(2008) C. L. Cooper et al.   CLINICAL INFECTIOUS DISEASES

Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study

(2008) Odile Launay et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Impaired Immunity to Recall Antigens and Neoantigens in Severely Immunocompromised Children and Adolescents during the First Year of Effective Highly Active Antiretroviral Therapy

(2008) Mona Rigaud et al.   JOURNAL OF INFECTIOUS DISEASES

ANTIBODY RESPONSE TO HEPATITIS A IMMUNIZATION AMONG HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AND ADOLESCENTS

(2008) George K. Siberry et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine

(2008) Sérgio Júlio Fernandes et al.   VACCINE

Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients

(2008) Mario Cruciani et al.   VACCINE